Prognosis of Patients With Relapsed/Refractory Hl Treated With Combination of Ifosfamide, Gemcitabine and Vinorelbine(IGEV) Induction Therapy Before High-dose Chemotherapy (HDCT) With Autologous Hematopoietic Stem Cells Transplantation (AHSCT)
Observational Model: Cohort, Time Perspective: Retrospective
The prognostic score will be defined taking into account Overall Survival (OS).
Surviving patents will be censored at the date of last known to be alive.
Armando Santoro, Prof.
Istituto Clinico Humanitas
Italy: National Monitoring Centre for Clinical Trials - Ministry of Health